BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou P, Gao G, Zhao CC, Li JY, Peng JF, Wang SS, Song R, Shi H, Wang L. In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity. Pharm Biol 2022;60:638-51. [PMID: 35298357 DOI: 10.1080/13880209.2022.2046801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li JY, Zhao CC, Peng JF, Zhang M, Wang L, Yin G, Zhou P. The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway. Evid Based Complement Alternat Med 2022;2022:1234434. [PMID: 36506810 DOI: 10.1155/2022/1234434] [Reference Citation Analysis]
2 Chen Y, Shi S, Dai Y. Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy. Biomedicine & Pharmacotherapy 2022;156:113903. [DOI: 10.1016/j.biopha.2022.113903] [Reference Citation Analysis]
3 Zha X, Li G, Zhang L, Chen Q, Xia Q. Identification of active compounds in Ophiopogonis Radix from different geographical origins by UPLC-Q/TOF-MS combined with GC-MS approaches. Open Life Sci 2022;17:865-80. [PMID: 36045721 DOI: 10.1515/biol-2022-0096] [Reference Citation Analysis]
4 Wang H, Yang G, Tian Y, Li J, Meng L, Jiang X, Xin Y. Sulforaphane inhibits angiotensin II-induced cardiomyocyte apoptosis by acetylation modification of Nrf2. Aging (Albany NY) 2022;14:6740-55. [PMID: 36006435 DOI: 10.18632/aging.204247] [Reference Citation Analysis]
5 Hua F, Li JY, Zhang M, Zhou P, Wang L, Ling TJ, Bao GH. Kaempferol-3-O-rutinoside exerts cardioprotective effects through NF-κB/NLRP3/Caspase-1 pathway in ventricular remodeling after acute myocardial infarction. J Food Biochem 2022;:e14305. [PMID: 35758877 DOI: 10.1111/jfbc.14305] [Reference Citation Analysis]